Mitochondrial Support

1. Physiol Rev. 1998Apr;78(2):547-81.
2. Ann N Y Acad Sci. 2004 Jun;1019:406-11.
3. Age. 1983 6:86-94.
4. Exp. Gerontol. 1984 19: 31-6.
5. Proc Natl Acad Sci USA. 1994 91:10771-8.
6. Proc Natl Acad Sci USA. 1997 94:3064-9.
7. Ann NY Acad. Sci. 1998; 854:118-27.
8. Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17.
9. Clin Sports Med. 1999Jul;18(3):485-98.
10. Int J Sports Med. 1998 May;19(4):231-44.
11. Hormones (Athens). 2008 Apr-Jun;7(2):123-32.
12. Protein Pept Lett. 2008;15(4):385-91.
13. J Alzheimers Dis. 2007 May;11(2):229-40.
14. Ann N Y Acad Sci. 2006 May;1067:369-74.
15. Sci Aging Knowledge Environ. 2005 May 4;2005(18):pe12.
16. Life Sci. 2007 Nov 30;81(23-24):1602-14.
17. J Nutr. 2006 Jun;136(6):1517-21.
18. J Neuroinflammation. 2008 Sep 25;5:41.
19. Immunology. 2005 Jul;115(3):375-87.
20. Am J Respir Crit Care Med. 2002 Mar 15;165(6):818-23.
21. Eur J Pharmacol. 2006 Jul 10;541(1-2):95-105.
22. Neurosci Lett. 2008 Dec 26;448(2):175-9.
23. Nat Med. 2003 Mar;9(3):294-9.
24. Acta Diabetol. 2001;38(3):135-8.
25. Diabetes. 2006 Aug;55(8):2231-7.
26. Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):371-7
27. J Lipid Res. 2006 May; 47(5): 964-74
28a. Biochem Biophys Acta. 2001 Feb 14;1535(2):110-9
28b. J Am Soc Nephrol. 2005 Jan;16(1):144-50.
28c. Life Sci. 1988;43(21):1725-31.
29. Biochem Biophys Res Commun. 1996 Apr 16;221(2):422-9.
30. FASEB J. 1999 Feb;13(2):411-8.
31. Antioxid Redox Signal. 2000 Fall;2(3):473-83.
32. Biochem Mol Biol Int. 1995 Oct;37(2):361-70.
33. Arch Biochem Biophys. 2004 Mar 1;423(1):126-35.
34. Altern Med Rev. 2005 Dec;10(4):268-93.
35. Neurosci Lett. 1994 Jan 3;165(1-2):33-6.
36. Neurochem Res. 1995 Jan;20(1):1-9.
37. Biofactors. 1999;9(2-4):371-8.
38. Lipids. 1989 Jul;24(7):579-84.
39. Mol Aspects Med. 1994;15 Suppl:s165-s175.
40. Mol Biotechnol. 2007 Sep;37(1):31-7.
41. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28.
42. KANEKA CORP. Anti-fatigue effect in rats. Unpublished data, Kaneka Corp.
43. Exp Gerontol. 2006 Feb;41(2):130-40.
44. Ubiquinol has a higher bioavailability compared to ubiquinone. Unpublished data, Kaneka Corp.
45. Plasma levels of COQ10 for ubiquinol increased dose dependently. Unpublished data, Kaneka Corp.
46. LEF internal unpublished study 2006
47. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
48. Free Radic Biol Med. 1999 Mar;26(5-6):685-94.
49. Biochem Mol Biol Int. 1998 Oct;46(3):585-95.
50. Am J Physiol. 1997 Jul;273(1 Pt 1):E185-E191.
51. Diabetes. 1996 Dec;45(12):1798-804.
52. Biochem Biophys Res Commun. 1996 Apr 16;221(2):422-9.
53. Biochem Pharmacol. 1996 Feb 9;51(3):233-8.
54. J Mol Cell Cardiol. 1995 Sep;27(9):1895-903.
55. Skin Pharmacol. 1994;7(5):278-84.
56. Z Naturforsch [C]. 1994 Sep-Oct;49(9-10):691-2.
57. Carlson DA, et al. Lipoic Acid: Energy Production, Antioxidant Activity and Health Effects. Taylor & Francis Publishers; 2008:235-70.
58. Med Rev. 2007 Dec;12(4):343-51.
59. Int J Sport Nutr Exerc Metab.2008 Feb;18(1):19-36.
60. J Physiol. 2007 Jun 1;581(Pt 2):431-44. Epub 2007 Mar 1.
61. Exp Physiol. 2008 Oct;93(10):1139-46.
62. Mol Aspects Med. 2004 Oct-Dec;25(5-6):533-49.
63. Clin Exp Pharmacol Physiol. 2006 Aug;33(8):725-33.
64. Neuropharmacology. 2008 Aug;55(2):223-9.
65. Neuropharmacology. 2006 Jun;50(8):917-23.
66. J Neurosci Res. 1991 Nov;30(3):555-9.
67. Neurochem Res. 1993 May;18(5):573-8.
68. Mol Cell Biochem.2003 Dec;254(1-2):227-34
69. Neurochem Res. 2008 Nov 1. [Epub ahead of print]
70. Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Jun;28(3):113-20.
71. Mol Aspects Med. 2004 Oct-Dec;25(5-6):551-67.
72. Ann N Y Acad Sci. 2002 Apr;959:491-507.
73. Brain Res Brain Res Rev. 2003 Mar;41(2-3):306-23.
74. Aging Cell. 2004 Aug;3(4):169-76.
75. Front Biosci. 2004 May 1;9:1100-17.
76. J Nutr. 1955 Feb 10;55(2):289-303.
77. Am J Pathol. 2007 Jun;170(6):1893-902.
78. Biochem J. 2006 Oct 15;399(2):e11-3.
79. Biogerontology. 2004;5(6):365-73.
80. Nephron Clin Pract. 2007;107(1):c26-34.
81. J Alzheimers Dis. 2007 May;11(2):229-40.
82. FEBS Lett. 2007 Mar 6;581(5):1067-70.
83. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):120-6.
84. Biochim Biophys Acta. 1984 May 16;772(2):209-19.
85. Exp Gerontol. 1990;25(2):127-34.
86. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2356-61.
87. Neurochem Res. 2008 Jan;33(1):194-203.
88. Proc Natl Acad Sci U S A 2002 May 14;99(10):7184
89. J Appl Physiol. 1999 Apr;86(4):1191-6.
90. Chem Biol Interact. 2006 Nov 7;163(3):192-8.
91. Nutrition. 2007 Jan;23(1):76-80.
92. Complement Ther Med. 1999 Sep;7(3):126-31.
93. FEBS Lett. 1999 Jan 8;442(1):89-94.
94. FEBS Lett.  1999 Jan 8;442(1):89-94.
95. Exp Clin Endocrinol Diabetes. 2001;109(6):330-6.
96. Exp Clin Endocrinol Diabetes. 1996;104(4):311-6.
97. Nat Med. 2003 Mar;9(3):294-9.
98. Toxicology. 2003 Feb 1;183(1-3):133-42.
99. Immunopharmacology. 1982 Apr;4(2):125-38.
100. Biochim Biophys Acta. 1977 Aug 15;469(1):52-60.
101. J Cell Biochem. 2004 May 15;92(2):285-95.
102. Carcinogenesis. 1998 Sep;19(9):1583-9.
103. J Rheumatol. 1997 Sep;24(9):1680-4
104. Science. 1977 Jan 14;195(4274):205-6.
105. Yao Xue Xue Bao. 2003 Aug;38(8):574-7.
106. Phytother Res. 2008 Apr;22(4):539-43.
107. Jpn J Pharmacol. 2001 Mar;85(3):322-6.
108. Invest Ophthalmol Vis Sci. 1979 Mar;18(3):237-41.
109. Am J Physiol Cell Physiol. 2007 Oct;293(4):C1395-403.
110. Pharmacol Ther. 2007 Jan;113(1):154-64.
111. Toxicol Lett. 2005 Dec 30;160(1):1-7.
112. Chem Biol Interact. 2004 Apr 15;147(3):259-71.
113. Chem Biol Interact. 2001 Nov 28;138(2):189-98.
114. Neurochem Res. 2007 Sep;32(9):1552-8
115. Drug Metab Rev. 1998 May;30(2):245-75.
116. Free Radic Biol Med. 1997;22(1-2):359-78.
117. Free Radic Biol Med. 2001 Jul 1;31(1):53-61.
118. Z Naturforsch [C]. 1998 Mar-Apr;53(3-4):250-3.